He came across the basic concept in papers by a Merck (nyse: MRK - news - people ) scientist named Catherine Strader while he was studying for his Ph.
FORBES: Magazine Article
2.
"We always thought of it as closing your eyes and feeling your way around the receptor, " says Strader, who now heads biology drug discovery at Schering-Plough (nyse: SGP - news - people ).